Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000497483 | SCV000590347 | likely benign | not provided | 2021-09-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000497483 | SCV001118771 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001102741 | SCV001259428 | benign | Thrombocytopenia 2 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Genome- |
RCV001102741 | SCV002539473 | benign | Thrombocytopenia 2 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genetics and Molecular Pathology, |
RCV001102741 | SCV002761647 | benign | Thrombocytopenia 2 | 2019-10-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000497483 | SCV005227636 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ARUP Laboratories, |
RCV001102741 | SCV005876243 | likely benign | Thrombocytopenia 2 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000497483 | SCV001550043 | likely benign | not provided | no assertion criteria provided | clinical testing | The ANKRD26 p.Ile1482Thr variant was not identified in the literature but was identified in dbSNP (ID: rs80097260), ClinVar (classified as uncertain significance by GeneDx) and LOVD 3.0 (classified as likely benign). The variant was identified in control databases in 1222 of 280530 chromosomes (3 homozygous) at a frequency of 0.004356 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (Finnish) in 224 of 24996 chromosomes (freq: 0.008961), European (non-Finnish) in 830 of 128428 chromosomes (freq: 0.006463), Other in 33 of 7132 chromosomes (freq: 0.004627), Latino in 99 of 35336 chromosomes (freq: 0.002802), African in 29 of 24190 chromosomes (freq: 0.001199), South Asian in 5 of 30586 chromosomes (freq: 0.000164), Ashkenazi Jewish in 1 of 10356 chromosomes (freq: 0.000097), and East Asian in 1 of 19506 chromosomes (freq: 0.000051). The p.Ile1482 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. | |
Laboratory of Diagnostic Genome Analysis, |
RCV000497483 | SCV001800522 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000497483 | SCV001967504 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003915355 | SCV004731634 | benign | ANKRD26-related disorder | 2020-09-23 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |